(Q33481110)

27 July 2017

title

Vitamin E treatment of haemolytic uraemic syndrome (English)

1 reference

27 July 2017

Powell HR

1

1 reference

27 July 2017

McCredie DA

2

1 reference

27 July 2017

Taylor CM

3

1 reference

27 July 2017

Burke JR

4

1 reference

27 July 2017

Walker RG

5

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 May 1984

1 reference

Archives of Disease in Childhood

27 July 2017

published in

1 reference

27 July 2017

volume

59

1 reference

27 July 2017

issue

5

1 reference

27 July 2017

page(s)

401-404

1 reference

Red cell membrane phospholipid abnormalities in the hemolytic uremic syndrome.

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

Haemolytic-uraemic syndrome: an analysis of prognostic features

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

Prostacyclin and renal diseases.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

The hemolytic-uremic syndrome in California: a review of 28 nonheparinized cases with long-term follow-up

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

Has heparin changed the prognosis of the hemolytic-uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

Vitamin E. An inhibitor of the platelet release reaction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

Treatment of the hemolytic uremic syndrome with plasma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628506

A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation

21 June 2018

1 reference

12 December 2020

Generation of prostacyclin-like substance and lipid peroxidation in vitamin E-deficient rats

1 reference

12 December 2020

Deficiency of plasma PGI2-like regenerating activity in neonatal plasma. Reversal by vitamin E in vitro

1 reference

12 December 2020

Studies of the generalized Shwartzman reaction produced by diet. IV. Ethyl ester fractions of cod liver oil and dihydroxystearic acid

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.59.5.401

1 reference

27 July 2017

1 reference

27 July 2017

1 reference